PMID: 9543646Apr 17, 1998Paper

An acute dose of nicotine enhances cue-induced cocaine craving

Drug and Alcohol Dependence
Malcolm S ReidS P Berger

Abstract

The present study examined whether the active component in tobacco, nicotine, can modulate cocaine craving in patients with a history of smoking crack cocaine when exposed to crack cocaine related environmental cues. Twenty patients, all cigarette smokers, were randomly assigned to nicotine (two 22 mg transdermal patches) or placebo in a single-dose, placebo-controlled, crossover, double-blind study. Craving and anxiety were measured before and after cocaine cues with visual analog scales for desire to use cocaine and mood. Skin conductance and skin temperature were recorded before and during cocaine cues. Following exposure to cocaine cues, all patients reported an increase in cocaine craving and anxiety relative to the pre-cue measures. Cue exposure also produced an increase in skin conductance and decrease in skin temperature. The cue-induced increase in cocaine craving was strongly enhanced by nicotine, while the increase in anxiety was slightly augmented. Cue-induced skin conductance and temperature responses were unaffected by nicotine. These findings show that cue-induced cocaine craving is enhanced by nicotine. This occurred in the absence of any tobacco smoking-related cues, suggesting that nicotine may have direct psy...Continue Reading

References

Jun 1, 1977·Pharmacology, Biochemistry, and Behavior·D C RobertsH C Fibiger
Nov 1, 1979·Pharmacology, Biochemistry, and Behavior·W H LynessK E Moore
Jan 1, 1992·Journal of Substance Abuse Treatment·P J Frawley, J W Smith
Nov 1, 1992·British Journal of Addiction·H R Kranzler, L O Bauer
Jan 1, 1992·Psychopharmacology·R N EhrmanC P O'Brien
Jun 28, 1992·Annals of the New York Academy of Sciences·C P O'BrienR Ehrman
Sep 1, 1991·The American Journal of Psychiatry·S T HigginsJ W Fenwick
Jan 1, 1990·Psychopharmacology·S T HigginsJ W Fenwick
Jan 1, 1990·The International Journal of the Addictions·D J RohsenowP M Monti
Feb 1, 1990·British Journal of Addiction·J E HenningfieldW Pollin
Dec 1, 1989·The American Journal of Medicine·N A Ettinger, R J Albin
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Di Chiara, A Imperato
Jan 1, 1987·Psychopharmacology·R Nemeth-CoslettR R Griffiths
May 1, 1986·The American Journal of Cardiology·L L Cregler, H Mark
Jan 1, 1986·Journal of Substance Abuse Treatment·A R ChildressC P O'Brien
Dec 16, 1986·European Journal of Pharmacology·A ImperatoG Di Chiara
Sep 12, 1985·The New England Journal of Medicine·I J ChasnoffK A Burns
Jan 1, 1974·Journal of Psychiatric Research·H C Fibiger, A G Phillips
Jan 1, 1983·Pharmacology & Therapeutics·K Wesnes, D M Warburton
Jan 1, 1984·Addictive Behaviors·R B LowR J Cadoret
Oct 1, 1981·Clinical Pharmacology and Therapeutics·J E Henningfield, R R Griffiths
Jan 1, 1980·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Jun 1, 1994·Journal of Applied Physiology·L HanssonR W Fuller
Jun 1, 1994·Perceptual and Motor Skills·T HoriM Takagi
Jan 1, 1993·Journal of Substance Abuse·A J BudneyW K Bickel
Mar 1, 1993·Journal of Substance Abuse Treatment·K L Sees, H W Clark
Feb 24, 1996·Lancet·S P BergerS Hall
Aug 25, 1997·Drug and Alcohol Dependence·R W Foltin, M W Fischman

❮ Previous
Next ❯

Citations

Jul 12, 2002·Psychopharmacology·Anita J Bechtholt, Gregory P Mark
Sep 10, 2011·Psychopharmacology·Daniel S McGrathEvan A Schmid
Mar 10, 2004·Pharmacology, Biochemistry, and Behavior·M L AndersenS Tufik
Jul 26, 2002·Brain Research·Andrew B NormanVladimir L Tsibulsky
Jun 23, 2001·Pharmacology, Biochemistry, and Behavior·E M KouriS E Lukas
May 17, 2001·Clinical Therapeutics·J M YoungT P George
Mar 9, 2000·Drug and Alcohol Dependence·S J RobbinsC P O'Brien
Apr 13, 2011·Experimental and Clinical Psychopharmacology·Nancy K Mello, Jennifer L Newman
Jun 24, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xiu LiuRussell E Poland
Oct 12, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark J Williams, Bryon Adinoff
Jan 18, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Daniel S McGrathPauwlina R McGrath
Jan 23, 2010·Behavioural Pharmacology·Karine Guillem, Laura L Peoples
Aug 23, 2011·The Journal of Pharmacology and Experimental Therapeutics·Robert W GouldMichael A Nader
Jun 27, 2014·Pharmacology, Biochemistry, and Behavior·Deanne M BuffalariEric C Donny
Mar 24, 2005·European Addiction Research·Ivan BerlinStephen J Heishman
Jan 23, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nancy K MelloStephen J Kohut
Mar 27, 2013·La Presse médicale·Laurent KarilaMichel Reynaud
Dec 18, 2010·Drug and Alcohol Dependence·P T HarrellD A Gorelick
Dec 5, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Cleo L CrunelleWim van den Brink
Apr 21, 2009·Drug and Alcohol Dependence·Malcolm S Reid, Vatsal Thakkar
Oct 24, 2007·Journal of Substance Abuse Treatment·Malcolm S ReidJohn Rotrosen
Nov 26, 2009·Drug and Alcohol Review·Daniel S McGrath, Sean P Barrett
Apr 19, 2005·Addictive Behaviors·F Joseph McClernon, Jed E Rose
Jul 9, 2004·Addictive Behaviors·Jill M Williams, Douglas Ziedonis
Sep 27, 2005·Pharmacology, Biochemistry, and Behavior·Thomas F NewtonWalter Ling
Apr 17, 2015·Annals of the New York Academy of Sciences·Kalynda K Gonzales, Yoland Smith
Apr 2, 2013·Pharmacology, Biochemistry, and Behavior·Alex J BrewerRichard De La Garza
Jun 7, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Joshua C MageeTheresa Winhusen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here